Cytodyn Stock Buy Hold or Sell Recommendation
| CYDY Stock | USD 0.14 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Cytodyn is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Cytodyn given historical horizon and risk tolerance towards Cytodyn. When Macroaxis issues a 'buy' or 'sell' recommendation for Cytodyn, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Cytodyn Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Cytodyn and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Cytodyn. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Cytodyn |
Execute Cytodyn Buy or Sell Advice
The Cytodyn recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cytodyn. Macroaxis does not own or have any residual interests in Cytodyn or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cytodyn's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Cytodyn Trading Alerts and Improvement Suggestions
| Cytodyn had very high historical volatility over the last 90 days | |
| Cytodyn has some characteristics of a very speculative penny stock | |
| Cytodyn has a very high chance of going through financial distress in the upcoming years | |
| Cytodyn currently holds 37.35 M in liabilities. Cytodyn has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Cytodyn until it has trouble settling it off, either with new capital or with free cash flow. So, Cytodyn's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cytodyn sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cytodyn to invest in growth at high rates of return. When we think about Cytodyn's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 266 K. Net Loss for the year was (210.82 M) with loss before overhead, payroll, taxes, and interest of (73.28 M). | |
| Cytodyn currently holds about 4.68 M in cash with (77.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Cytodyn current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cytodyn analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cytodyn analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Cytodyn Returns Distribution Density
The distribution of Cytodyn's historical returns is an attempt to chart the uncertainty of Cytodyn's future price movements. The chart of the probability distribution of Cytodyn daily returns describes the distribution of returns around its average expected value. We use Cytodyn price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cytodyn returns is essential to provide solid investment advice for Cytodyn.
| Mean Return | 0.13 | Value At Risk | -7.14 | Potential Upside | 11.11 | Standard Deviation | 6.77 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cytodyn historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cytodyn Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cytodyn or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cytodyn's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cytodyn otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.19 | |
β | Beta against Dow Jones | -1.04 | |
σ | Overall volatility | 6.93 | |
Ir | Information ratio | 0.01 |
Cytodyn Volatility Alert
Cytodyn is showing large volatility of returns over the selected time horizon. Cytodyn is a potential penny stock. Although Cytodyn may be in fact a good instrument to invest, many penny otc stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Cytodyn. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Cytodyn instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Cytodyn Fundamentals Vs Peers
Comparing Cytodyn's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cytodyn's direct or indirect competition across all of the common fundamentals between Cytodyn and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cytodyn or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cytodyn's fundamental indicators could also be used in its relative valuation, which is a method of valuing Cytodyn by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cytodyn to competition |
| Fundamentals | Cytodyn | Peer Average |
| Return On Asset | -1.48 | -0.14 |
| Current Valuation | 286.7 M | 16.62 B |
| Shares Outstanding | 832.97 M | 571.82 M |
| Shares Owned By Insiders | 7.91 % | 10.09 % |
| Shares Owned By Institutions | 0.06 % | 39.21 % |
| Price To Earning | (3.14) X | 28.72 X |
| Price To Book | 1,066 X | 9.51 X |
| Price To Sales | 1,174 X | 11.42 X |
| Revenue | 266 K | 9.43 B |
| Gross Profit | (73.28 M) | 27.38 B |
| EBITDA | (157.59 M) | 3.9 B |
| Net Income | (210.82 M) | 570.98 M |
| Cash And Equivalents | 4.68 M | 2.7 B |
| Cash Per Share | 0.01 X | 5.01 X |
| Total Debt | 37.35 M | 5.32 B |
| Current Ratio | 0.08 X | 2.16 X |
| Book Value Per Share | (0.14) X | 1.93 K |
| Cash Flow From Operations | (77.72 M) | 971.22 M |
| Earnings Per Share | (0.23) X | 3.12 X |
| Target Price | 4.0 | |
| Number Of Employees | 23 | 18.84 K |
| Beta | 0.2 | -0.15 |
| Market Capitalization | 233.23 M | 19.03 B |
| Total Asset | 29.18 M | 29.47 B |
| Retained Earnings | (211.86 M) | 9.33 B |
| Working Capital | (371.16 K) | 1.48 B |
| Current Asset | 136.91 K | 9.34 B |
| Current Liabilities | 508.07 K | 7.9 B |
| Z Score | -22.7 | 8.72 |
| Net Asset | 29.18 M |
Cytodyn Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cytodyn . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cytodyn Buy or Sell Advice
When is the right time to buy or sell Cytodyn? Buying financial instruments such as Cytodyn OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cytodyn in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Natural Foods Thematic Idea Now
Natural Foods
Companies producing natural foods including dairy products and different types of meets. The Natural Foods theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Natural Foods Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Cytodyn OTC Stock Analysis
When running Cytodyn's price analysis, check to measure Cytodyn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytodyn is operating at the current time. Most of Cytodyn's value examination focuses on studying past and present price action to predict the probability of Cytodyn's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytodyn's price. Additionally, you may evaluate how the addition of Cytodyn to your portfolios can decrease your overall portfolio volatility.